ESIDRIX Drug Patent Profile
✉ Email this page to a colleague
When do Esidrix patents expire, and what generic alternatives are available?
Esidrix is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in ESIDRIX is hydrochlorothiazide. There are thirty-two drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Esidrix
A generic version of ESIDRIX was approved as hydrochlorothiazide by PRINSTON INC on March 29th, 2002.
Summary for ESIDRIX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 134 |
Clinical Trials: | 2 |
Patent Applications: | 3,817 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ESIDRIX at DailyMed |
Recent Clinical Trials for ESIDRIX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Scripps Translational Science Institute | N/A |
Novartis | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for ESIDRIX
US Patents and Regulatory Information for ESIDRIX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | ESIDRIX | hydrochlorothiazide | TABLET;ORAL | 011793-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novartis | ESIDRIX | hydrochlorothiazide | TABLET;ORAL | 011793-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novartis | ESIDRIX | hydrochlorothiazide | TABLET;ORAL | 011793-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |